Related Experiment Video
Updated: Aug 30, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy
S B Pai1, R B Pai, R F Schinazi
1Veterans Affairs Medical Center, Emory University School of Medicine, Decatur, GA 30033, USA. rpai@emory.edu
Abstract:
The worldwide problem of hepatitis B viral infection has been the focus of a large number of investigations. In the last decade advances have been made in the understanding of the viral function as well as strategies to combat the virus. Lamivudine, Hepsera, and interferon-alpha therapies that are currently used in the clinic are not optimal because of the emergence of resistance in the former modality and/or adverse effects. There are several new nucleosides that are under development for treatment of HBV. With the combination of a number of treatment protocols, it should be possible to bring down the viral load to undetectable levels and minimize the risk of generating mutations that confer resistance to the therapeutic agent.
Related Concept Videos
Hepatitis
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Viral Hepatitis I: Introduction
Viruses with RNA Genomes
